Abiopharma

BLINK CHARGING ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

Galapagos Announces Nomination of Gino Santini to its Board of Directors

📋 ARTURO MOLINA (Officer) plans to sell 15K shares of PROTAGONIST THERAPEUTICS, INC. (at $104.79 each, total $1.6M) Filed: Mar 26, 2026 | ID: 003011

Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings

SIGA - SIGA Declares Special Cash Dividend of $0.60 Per Share

(10% Negative) DARE BIOSCIENCE, INC. (DARE) Announces Delay in results Trials for earnest now Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity

Conkling Lori A 🟢 acquired 75 shares of Interactive Brokers Group, Inc. (IBKR) at $73.21 Transaction Date: Feb 25, 2026 | Filing ID: 000068

Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings

Galapagos publiceert 2025 jaarverslag en kondigt de Gewone (jaarlijkse) en Buitengewone Algemene Vergaderingen aan

Newton Golf to Present at the Emerging Growth Conference on Thursday, April 2, 2026

Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update

McGrath First Quarter Earnings and Conference Call Scheduled for April 29, 2026

Seacoast Banking Corporation of Florida Appoints Three New Independent Directors

New Form 3 - Varex Imaging Corp <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0001681622-26-000040 <b>Size:</b> 378 KB